Complement activation appears to be central to the pathophysiology of SLE and, due to their cleavage to active C3b and C4b, decreased levels of C3 and C4 are seen in SLE flares and are also included in the classification criteria for SLE [10,23,44]. The gene discussed is C4A; the disease is systemic lupus erythematosus.